Abstract

Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply.
Jonas Bovijn ... Michael V Holmes
The Lancet Rheumatology | VOL. 3
Jonas Bovijn, et. al.Jonas Bovijn ... Michael V Holmes
15 Dec 2020
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
Tara M. Narowski ... Lakshmanane Premkumar
Cell Reports | VOL. 38
Tara M. Narowski, et. al.Tara M. Narowski ... Lakshmanane Premkumar
20 Jan 2022
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong ... Lingli Dong
The Lancet Rheumatology | VOL. 2
Jixin Zhong, et. al.Jixin Zhong ... Lingli Dong
20 May 2020
SARS-CoV-2's origin should be investigated worldwide for pandemic prevention
Zhiqiang Wu ... Chen Wang
The Lancet | VOL. 398
Zhiqiang Wu, et. al.Zhiqiang Wu ... Chen Wang
17 Sep 2021
View more papers

More From: The Lancet Rheumatology

Paper Title
Journal
Date
Author
Proliferative features of IgG4-related disease.
Guy Katz ... Diego Palumbo
The Lancet Rheumatology | VOL. 6
Guy Katz, et. al.Guy Katz ... Diego Palumbo
01 Jul 2024
Welcome new evidence on self-management of back pain.
Chris Maher ... Chung-Wei Christine Lin
The Lancet Rheumatology | VOL. 6
Chris Maher, et. al.Chris Maher ... Chung-Wei Christine Lin
01 Jul 2024
Contesting the BACPAP consortium's consensus - Authors' reply.
Eva Kosek ... Steven Z George
The Lancet Rheumatology | VOL. 6
Eva Kosek, et. al.Eva Kosek ... Steven Z George
01 Jul 2024
Systemic lupus erythematosus: managing cardiovascular risk factors
Anisur Rahman
The Lancet Rheumatology | VOL. 6
Anisur RahmanAnisur Rahman
01 Jul 2024
View more papers